Mitophagy in neurodegeneration and aging

Neurochemistry International

Volumn 109, Issue , 2017, Pages 202-209

  Fivenson, Elayne M ^a   Lautrup, Sofie ^a,b   Sun, Nuo ^c   Scheibye Knudsen, Morten ^d   Stevnsner, Tinna ^b   Nilsen, Hilde ^e   Bohr, Vilhelm A ^a,d   Fang, Evandro F ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; NATURAL PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE; PARKIN; PINK1 PROTEIN; PROTEIN; RESVERATROL; SIRTUIN; UNCLASSIFIED DRUG;

AGING; CAENORHABDITIS ELEGANS; ENERGY; GENE MUTATION; HOMEOSTASIS; HUMAN; MAMMAL CELL; MITOCHONDRION; MITOPHAGY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; YEAST; ANIMAL; AUTOPHAGY; DEGENERATIVE DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; AUTOPHAGY; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; NEURODEGENERATIVE DISEASES;

EID: 85015680386     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2017.02.007     Document Type: Review

References (107)

1. Bauer, J.H., et al. dSir2 and Dmp53 interact to mediate aspects of CR-dependent life span extension in D. melanogaster. Aging, 1(1), 2009, 38.
2. Bingol, B., et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510:7505 (2014), 370–375.
3. Boily, G., et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One, 3(3), 2008, e1759.
4. Bonkowski, M.S., Sinclair, D.A., Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat. Rev. Mol. Cell Biol. 17:11 (2016), 679–690.
5. Bossy-Wetzel, E., Petrilli, A., Knott, A.B., Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci. 31:12 (2008), 609–616.
6. Braidy, N., et al. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One, 6(4), 2011, e19194.
7. Bratic, A., Larsson, N.-G., The role of mitochondria in aging. J. Clin. Investig. 123:3 (2013), 951–957.
8. Cantó, C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:7241 (2009), 1056–1060.
9. Cantó, C., Menzies, K.J., Auwerx, J., NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell metab. 22:1 (2015), 31–53.
10. Casley, C., et al. β-Amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10:3 (2002), 258–267.
11. Chen, S., et al. RAD6 promotes homologous recombination repair by activating the autophagy-mediated degradation of heterochromatin protein HP1. Mol. Cell Biol. 35:2 (2015), 406–416.
12. Chen, M., et al. Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. Autophagy 12:4 (2016), 689–702.
13. Cheng, A., et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat. Commun., 3, 2012, 1250.
14. Cheng, A., et al. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell metab. 23:1 (2016), 128–142.
15. Chow, H.-m., Herrup, K., Genomic integrity and the ageing brain. Nat. Rev. Neurosci. 16:11 (2015), 672–684.
16. Clark, I.E., et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:7097 (2006), 1162–1166.
17. Cornelissen, T., et al. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum. Mol. Genet. 23:19 (2014), 5227–5242.
18. Corral-Debrinski, M., et al. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat. Genet. 2:4 (1992), 324–329.
19. Deng, H., et al. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 105:38 (2008), 14503–14508.
20. Ding, W.X., et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J. Biol. Chem. 285:36 (2010), 27879–27890.
21. Durcan, T.M., et al. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J., 2014, e201489729.
22. Egan, D.F., et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331:6016 (2011), 456–461.
23. Fang, E.F., Bohr, V.A., NAD+: the convergence of DNA repair and mitophagy. Autophagy, 2016, 1–2.
24. Fang, E.F., et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 157:4 (2014), 882–896.
25. Fang, E.F., et al. Nuclear DNA damage signalling to mitochondria in ageing. Nat. Rev. Mol. Cell Biol. 17:5 (2016), 308–321.
26. Fang, E.F., et al. NAD+ replenishment improves lifespan and healthspan in Ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24:4 (2016), 566–581.
27. Fayet, G., et al. Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function. Neuromuscul. Disord. 12:5 (2002), 484–493.
28. Fimia, G.M., et al. Ambra1 regulates autophagy and development of the nervous system. Nature 447:7148 (2007), 1121–1125.
29. Gautier, C.A., Kitada, T., Shen, J., Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc. Natl. Acad. Sci. 105:32 (2008), 11364–11369.
30. Gibson, B.A., Kraus, W.L., New insights into the molecular and cellular functions of poly (ADP-ribose) and PARPs. Nat. Rev. Mol. Cell Biol. 13:7 (2012), 411–424.
31. Gomes, A.P., et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155:7 (2013), 1624–1638.
32. Greene, J.C., et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U. S. A. 100:7 (2003), 4078–4083.
33. Haigis, M.C., Sinclair, D.A., Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol., 5, 2010, 253.
34. Hara, T., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:7095 (2006), 885–889.
35. Hasson, S.A., et al. Chemogenomic profiling of endogenous PARK2 expression using a genome-edited coincidence reporter. ACS Chem. Biol. 10:5 (2015), 1188–1197.
36. Hertz, N.T., et al. A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1. Cell 154:4 (2013), 737–747.
37. Houtkooper, R.H., Pirinen, E., Auwerx, J., Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13:4 (2012), 225–238.
38. Howitz, K.T., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:6954 (2003), 191–196.
39. Hudson, E., et al. Age-associated change in mitochondrial DNA damage. Free Radic. Res. 29:6 (1998), 573–579.
40. Hwang, S., Disatnik, M.H., Mochly-Rosen, D., Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease. EMBO Mol. Med. 7:10 (2015), 1307–1326.
41. Imai, S.-i., Guarente, L., NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24:8 (2014), 464–471.
42. Imai, S.-i., Guarente, L., It takes two to tango: NAD+ and sirtuins in aging/longevity control. npj Aging Mech. Dis., 2, 2016, 16017.
43. Jain, I.H., et al. Hypoxia as a therapy for mitochondrial disease. Science 352:6281 (2016), 54–61.
44. Kameshita, I., et al. Poly (ADP-Ribose) synthetase. Separation and identification of three proteolytic fragments as the substrate-binding domain, the DNA-binding domain, and the automodification domain. J. Biol. Chem. 259:8 (1984), 4770–4776.
45. Kanfi, Y., et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 483:7388 (2012), 218–221.
46. Kerr, J.S., et al. Mitophagy and Alzheimer's disease: cellular and molecular mechanisms. Trends Neurosci., 2017, 10.1016/j.tins.2017.01.002 (in press), pii: S0166-2236(17)30005-X, PMID:28190529.
47. Khalil, B., et al. PINK1-induced mitophagy promotes neuroprotection in Huntington's disease. Cell death Dis., 6(1), 2015, e1617.
48. Kitada, T., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:6676 (1998), 605–608.
49. Komatsu, M., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441:7095 (2006), 880–884.
50. Larsson, N.-G., Somatic mitochondrial DNA mutations in mammalian aging. Annu. Rev. Biochem. 79 (2010), 683–706.
51. Lazarou, M., et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524:7565 (2015), 309–314.
52. Lemasters, J.J., Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 8:1 (2005), 3–5.
53. Liu, L., et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14:2 (2012), 177–185.
54. López-Otín, C., et al. The hallmarks of aging. Cell 153:6 (2013), 1194–1217.
55. Madeo, F., Tavernarakis, N., Kroemer, G., Can autophagy promote longevity?. Nat. Cell Biol. 12:9 (2010), 842–846.
56. Massudi, H., et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One, 7(7), 2012, e42357.
57. McLelland, G.L., et al. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J., 2014, e201385902.
58. Menzies, F.M., Fleming, A., Rubinsztein, D.C., Compromised autophagy and neurodegenerative diseases. Nat. Rev. Neurosci. 16:6 (2015), 345–357.
59. Mihaylova, M.M., Shaw, R.J., The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13:9 (2011), 1016–1023.
60. Mills, K.F., et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 24:6 (2016), 795–806.
61. Moore, A.S., Holzbaur, E.L., Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc. Natl. Acad. Sci. U. S. A., 113(24), 2016 E3349-E3358.
62. Mouchiroud, L., et al. The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154:2 (2013), 430–441.
63. Murakawa, T., et al. Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. Nat. Commun., 6, 2015, 7527.
64. Neuspiel, M., et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr. Biol. 18:2 (2008), 102–108.
65. Palacino, J.J., et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279:18 (2004), 18614–18622.
66. Palikaras, K., Tavernarakis, N., Mitophagy in neurodegeneration and aging. Front. Genet., 3, 2012, 297.
67. Palikaras, K., Lionaki, E., Tavernarakis, N., Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 521:7553 (2015), 525–528.
68. Park, J., et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:7097 (2006), 1157–1161.
69. Park, D., et al. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci. Rep., 6, 2016.
70. Perez, F.A., Palmiter, R.D., Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl. Acad. Sci. U. S. A. 102:6 (2005), 2174–2179.
71. Pickrell, A.M., Youle, R.J., The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85:2 (2015), 257–273.
72. Pickrell, A.M., et al. Endogenous Parkin preserves dopaminergic substantia nigral neurons following mitochondrial DNA mutagenic stress. Neuron 87:2 (2015), 371–381.
73. Poole, A.C., et al. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. U. S. A. 105:5 (2008), 1638–1643.
74. Qin, W., et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281:31 (2006), 21745–21754.
75. Richter, U., et al. A mitochondrial ribosomal and RNA decay pathway blocks cell proliferation. Curr. Biol. 23:6 (2013), 535–541.
76. Rojansky, R., Cha, M.-Y., Chan, D.C., Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1. eLife, 5, 2016, e17896.
77. Rubinsztein, D.C., Mariño, G., Kroemer, G., Autophagy and aging. Cell 146:5 (2011), 682–695.
78. Rugarli, E.I., Langer, T., Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 31:6 (2012), 1336–1349.
79. Ryan, B.J., et al. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem. Sci. 40:4 (2015), 200–210.
80. Ryu, D., et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22:8 (2016), 879–888.
81. Sandoval, H., et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 454:7201 (2008), 232–235.
82. Scheibye-Knudsen, M., et al. A novel diagnostic tool reveals mitochondrial pathology in human diseases and aging. Aging (Albany NY) 5:3 (2013), 192–208.
83. Scheibye-Knudsen, M., et al. Protecting the mitochondrial powerhouse. Trends Cell Biol. 25:3 (2014), 158–170.
84. Scheibye-Knudsen, M., et al. Cockayne syndrome group A and B proteins converge on transcription-linked resolution of non-B DNA. Proc. Natl. Acad. Sci. U. S. A. 113:44 (2016), 12502–12507.
85. Schiavi, A., et al. Iron-starvation-induced mitophagy mediates lifespan extension upon mitochondrial stress in C. elegans. Curr. Biol. 25:14 (2015), 1810–1822.
86. Song, Y.M., et al. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. Autophagy 11:1 (2015), 46–59.
87. Song, W.H., et al. Autophagy and ubiquitin-proteasome system contribute to sperm mitophagy after mammalian fertilization. Proc. Natl. Acad. Sci. U. S. A., 113(36), 2016 E5261-E5270.
88. Soubannier, V., et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 22:2 (2012), 135–141.
89. Strappazzon, F., et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ., 22(3), 2015, 517.
90. Sugiura, A., et al. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J., 2014, e201488104.
91. Sun, N., et al. Measuring in vivo mitophagy. Mol. Cell 60:4 (2015), 685–696.
92. Sun, N., Youle, R.J., Finkel, T., The mitochondrial basis of aging. Mol. Cell 61:5 (2016), 654–666.
93. Tissenbaum, H.A., Guarente, L., Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410:6825 (2001), 227–230.
94. Trifunovic, A., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:6990 (2004), 417–423.
95. Valente, E.M., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:5674 (2004), 1158–1160.
96. Van Humbeeck, C., et al. Parkin interacts with Ambra1 to induce mitophagy. J. Neurosci. 31:28 (2011), 10249–10261.
97. Wallace, D.C., Mitochondrial diseases in man and mouse. Science 283:5407 (1999), 1482–1488.
98. Wallace, D.C., A mitochondrial bioenergetic etiology of disease. J. Clin. Investig. 123:4 (2013), 1405–1412.
99. Weydt, P., et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration. Cell metab. 4:5 (2006), 349–362.
100. Wiley, C.D., et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell metab. 23:2 (2016), 303–314.
101. Wu, W., et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep. 15:5 (2014), 566–575.
102. Yang, Y., et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. U. S. A. 103:28 (2006), 10793–10798.
103. Yang, Y., et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl. Acad. Sci. U. S. A. 105:19 (2008), 7070–7075.
104. Ye, X., et al. Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains. Hum. Mol. Genet. 24:10 (2015), 2938–2951.
105. Youle, R.J., Narendra, D.P., Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12:1 (2011), 9–14.
106. Yun, J., et al. MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin. Elife, 3, 2014, e01958.
107. Zhou, Q., et al. Mitochondrial endonuclease G mediates breakdown of paternal mitochondria upon fertilization. Science 353:6297 (2016), 394–399.